Citeline delivers the industry’s most robust, reliable, and relevant R&D intelligence
Expert analysts
Our extensive team of trial experts and analysts tracks over 30,000 information sources, delivering a unique combination of reliable data and unlimited personal research support.
225,000+ drug trials covered
Citeline covers every stage of drug development, featuring over 225,000 drug trials across 150 countries and more than 180 diseases.
Unlimited research support
Our PhD and MSc-level analysts conduct support research on your behalf at no additional cost, helping you to gain deeper competitive pharma business intelligence on specific trials within just 48 hours.
373,000+ active clinical trial investigator profiles
Citeline examines over 373,000 clinical trial investigators, assessing their ability as well as their expertise in specific pharmaceutical clinical trials, giving you access to the most extensive dataset of investigator expertise, experience and capacity.
Industry-leading benchmarking tools
Citeline has designed proprietary pharmaceutical clinical trial algorithms to help you better predict clinical trial timelines, from patient enrollment through study duration period and trial completion.
Seamless integration
The full suite of Citeline pharmaceutical clinical trial products has been developed to allow easy cross-navigation, allowing you to move seamlessly from pipeline analysis and drug trial records to profiles of clinical trial investigators.
Recent posts...
Pre-dialysis: A new patient segment for Trialtrove’s Anemia disease module
More than half of the 1898 anemia trials in Trialtrove evaluate the treatment or prevention of anemia due to chronic renal disease. Drug development programs for this indication usually recruit from two distinct patient populations: patients who are
Alzheimer’s Disease
Alzheimer’s Disease (AD) is the most common form of dementia, and accounts for 60% to 80% of dementia cases. In this progressive disease, dementia symptoms gradually worsen over a number of years. Memory loss is mild during early stages, but ind
Clinical trial landscape
Last year, Christine Blazynski, Head of Innovation, reported on the clinical trial landscape for trials that completed during 2014, highlighting diseases that enjoyed success and the companies backing those trials. Due to popular demand, Christine
Our Products
The Citeline family of pharmaceutical clinical trial intelligence products.
Track global clinical trials in real-time
Accurately forecast clinical trial timings
Follow every drug, from bench to market
Find the best investigator for your trial
Prequalify Chinese hospitals for your clinical trials
View the clinical trials landscape
Get tailored advice for your organization